Investigación sobre vacunas

06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for health...

05-01-2024A quick roundup of key topics of HIV.gov’s coverage of the 2024 Conference on Retroviruses and Opportunistic Infections from HIV testing, treatment, and P…

03-05-2024At the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov caught up again with Dr. LaRon Nelson to discuss community-engaged resear...

03-05-2024During the first full day of presentations at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), we spoke with NIH s Dr. Carl Dieffen...

09-26-2023Cross-posted from: NIAID newsroom Transmission electron micrograph of HIV-1 virus particles from infected H9 c...

08-10-2023The HIV community has lost a thoughtful leader and esteemed colleague. The HIV Vaccine Trials Network (HVTN) has...

07-25-2023On Tuesday at the International AIDS Society s 12th Conference on HIV Science (IAS 2023), HIV.gov continued our conversations about research highlights, inclu..…

05-08-2023Register now to take part in an important conversation about National HIV Vaccine Awareness Day an annual obse...

03-10-2023Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community...

02-22-2023As the latest research on HIV and other infectious diseases continued to be presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI)…

02-22-2023The ongoing search for an HIV vaccine was among the topics discussed during the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). HIV.gov spo…

09-12-2022Cross-posted from Centers for Disease Control and Prevention On Friday, September 9, 2022, CDC issued in its Mo...